Category

Cohort News

Acute results of the ASCEND EV study: A new modality of parasternal extravascular implantable cardioverter-defibrillator therapy including antitachycardia pacing featuring AtaCor Medical

//
Categories
Background Extravascular implantable cardioverter-defibrillators (EV-ICDs) are being developed to overcome limitations of current implantable cardioverter-defibrillators (ICDs). The AtaCor parasternal EV-ICD system uses an extravascular lead along the left parasternum to deliver defibrillation and pacing therapy from outside the heart. Objective...
Read More →

Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments

//
Categories
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 — Retia Medical today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Argos Infinity™, the company’s cardiovascular intelligence software platform designed for high-risk surgical...
Read More →
1 2 3 156